Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Where are the S&M boys?
View:
Post by Spamme54321 on Jun 14, 2022 10:16am

Where are the S&M boys?

Interesting that Spectral is moving and S&M boys are MIA
Comment by JohnnyCashMoney on Jun 14, 2022 10:20am
I am still sadistic and masochistic 
Comment by oilandgasman on Jun 14, 2022 10:21am
It ain't easy covering a short on the Canadian 
Comment by RickyBobbyTO on Jun 14, 2022 10:56am
I don't think there is a large short position here. If any at all. I will be a seller soon. Not my first rodeo for this pre-financing pump. Thank god they're on schedule.  
Comment by RickyBobbyTO on Jun 14, 2022 10:59am
Yes baby, RUN.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities